South Korea’s WIRobotics Takes the Spotlight at CES 2025, Plans Global Expansion

YONGIN, South Korea, Jan. 14, 2025 /PRNewswire/ — WIRobotics, the company behind the revolutionary wearable mobility solution WIM(We Innovate Mobility), has achieved a major milestone at CES 2025, one of the world’s premier technology trade shows. Featuring more than 4,500 companies from 166 countries showcasing cutting-edge innovations, the event set a new record this year, with WIRobotics emerging as one of its standout success stories.

At CES, held January 7–10 in Las Vegas, WIM, the company’s flagship wearable mobility device, earned the prestigious CES Innovation Award in Robotics for the second consecutive year. This recognition highlights the product’s global appeal and reinforces the company’s leadership in the rapidly growing field of wearable mobility.

We are thrilled by the overwhelmingly warm reception at CES,” said Yeon Baek Lee, Co-CEO of WIRobotics. “We’ve already had discussions with industry leaders like Best Buy, OttoBock, and several major hospitals and rehabilitation centres about global distribution and potential partnerships.”

WIM is a game-changer in the wearable technology sector. Weighing just 1.6 kilograms, the device can be worn by anyone in under 30 seconds. The wearable mobility solution integrates with a dedicated mobile app to analyze walking data, delivering a personalized, AI-driven walking experience. With multiple modes—assistance, exercise, and mountaineering—WIM offers versatile functionality that can cater to a wide range of user needs.

After its launch in Korea in April 2024, WIM quickly gained traction in the local market, selling around 500 units in just eight months. The success in Korea, where consumers are known for their high expectations and discerning tastes, has given WIRobotics the confidence to push forward with its global expansion plans.

The excitement surrounding WIM at CES was undeniable. Even before the official exhibition hours, hundreds of visitors lined up at the WIRobotics booth to experience the wearable mobility device firsthand. Extensive coverage by both domestic and international media outlets further amplified the company’s presence on the global stage.

Lee expressed optimism about the future, noting, “Despite some initial challenges in launching the product, we swiftly implemented improvements based on early customer feedback. That rapid response has driven our success in Korea, and we’re now looking to build on that momentum as we enter the U.S., European, and Japanese markets in 2025.”

As WIRobotics moves forward with its global expansion, the company plans to form strategic partnerships with global distributors and healthcare providers to broaden its reach. The goal is not only to grow the company’s international footprint but to improve the quality of life for individuals through innovative wearable mobility solutions.

With its impressive presence at CES 2025, WIRobotics has cemented its position as a key player in the wearable mobility industry, preparing itself for remarkable growth in the coming years.

About WIRobotic

WIRobotics, short for We Innovate Robotics, is dedicated to improving quality of life through wearable robotics. Following the success of WIBS (We Innovate Back Support), an unpowered back support wearable robot, the company launched WIM in 2024, earning CES Innovation Awards in both the Robotics and Accessibility & Aging Tech categories. WIRobotics continues to lead the charge toward a “one person, one robot” era by combining cutting-edge technology with hands-on consumer engagement.

For more information, visit www.wirobotics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/south-koreas-wirobotics-takes-the-spotlight-at-ces-2025-plans-global-expansion-302350400.html

SOURCE WIRobotics

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

19 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

2 days ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

2 days ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

2 days ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

2 days ago